Pharmacology & ToxicologybioRxivPreprint
Dose optimisation of favipiravir against RNA viruses using physiologically-based pharmacokinetic modelling.
William HJ Wood, Henry E. Pertinez, Tim Rowland…·Saye Khoo
This study optimizes favipiravir doses against RNA viruses using physiologically-based pharmacokinetic modeling, showing safe dosing ranges and effects of chronic kidney disease.
DOI 10.64898/2026.06.24.733995